You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study

Article info

Article menu

Download PDFPDF

XML
Emerging technologies and therapeutics
Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study

Authors

  • Thomas H Wieringa Department of Medical Psychology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Maartje de Wit Department of Medical Psychology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Jos WR Twisk Department of Clinical Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Frank J Snoek Department of Medical Psychology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Thomas H Wieringa; t.wieringa{at}vumc.nl
View Full Text

Citation

Wieringa TH, de Wit M, Twisk JW , , , et al
Improved diabetes medication convenience and satisfaction in persons with type 2 diabetes after switching to insulin glargine 300 U/mL: results of the observational OPTIN-D study
BMJ Open Diabetes Research and Care 2018;6:e000548. doi: 10.1136/bmjdrc-2018-000548

Publication history

  • Received May 4, 2018
  • Revised July 24, 2018
  • Accepted August 13, 2018
  • First published October 1, 2018.
Online issue publication 
January 14, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/